Questions. Drug Development in Collaborative Environments: a plea for Open Innovation

1753 visualizacións 22 de nov. de 2013

The Institute of Biomedical Research of Vigo (IBIV), within BIOCAPS´ Project Framework, has celebrated the “1st International Congress on Biomedical Research & Innovation” on the 21st and 22nd of November 2013 in Vigo, Spain.

The event highlights the most important R&D aspects related to the Biomedical Research and Innovation in the following fields: Neurological sciences and rare diseases; Infectious diseases, Inflammation and Immunity; Endocrinology, Metabolism and Nutrition; Biomaterials, Tissue engineering and Regenerative Medicine; New tools in diagnosis and therapy; Ageing and cardiovascular diseases; and Biomedical Innovation. In each field, renowned researchers expose their studies.

The congress is expected to become a point of reference for Biomedical Research and Innovation, transmitting scientific perspective and awareness among scientists, public bodies, enterprises and the society.

Antonio Fernández
Director, Business Development and Government Affairs, Johnson and Johnson

Introducing Andrew Mckenzie

África González-Fernandez - Coordinator

Type-2 innate lymphoid cells in immunity and disease

Andrew Mckenzie - MRC Laboratory of Molecular Biology

Questions. Type-2 innate lymphoid cells in immunity and disease

Andrew Mckenzie - MRC Laboratory of Molecular Biology

Introducing Luis Anibarro García

África González-Fernandez - Coordinator

Latent Tuberculosis Infection

Luis Anibarro García - Tuberculosis Unit

Questions. Latent Tuberculosis Infection

Luis Anibarro García - Tuberculosis Unit

Institutional Welcome

José Manuel Olivares Díez - Department of Psychiatry

Introducing Andre Fischer

Roberto Carlos Agis-Balboa - Senior Researcher

Epigenetic mechanisms in neuropsychiatric diseases

Andre Fischer - Dep. for Psychiatry and Psychotherapy

Questions. Epigenetic mechanisms in neuropsychiatric diseases

Andre Fischer - Dep. for Psychiatry and Psychotherapy

Introducing Robert Will

Carmen Navarro Fernández-Balbuena - Scientific Director

Pathogenesis and transmissibility of neurodegenerative diseases

Robert Will - Professor of Clinical Neurology, University of Edinburgh

Questions. Pathogenesis and transmissibility of neurodegenerative diseases

Robert Will - Professor of Clinical Neurology, University of Edinburgh

Introducing Saida Ortolano

Carmen Navarro Fernández-Balbuena - Scientific Director

Update in Fabry Disease

Saida Ortolano - Research Fellow, Neuroscience Group, Institute of Biomedical Research of Vigo

Questions. Update in Fabry Disease

Saida Ortolano - Research Fellow, Neuroscience Group, Institute of Biomedical Research of Vigo

Introducing María Berdasco

Angel Rodríguez de Lera - Professor of Organic Chemistry

Genetic Disruption of Epigenetic Enzymes in Human Disorders: impact on clinical management

María Berdasco - Cancer Epigenetics Laboratory, Cancer Epigenetics and Biology Program (PEBC)

Questions. Genetic Disruption of Epigenetic Enzymes in Human Disorders: impact on clinical management

María Berdasco - Cancer Epigenetics Laboratory, Cancer Epigenetics and Biology Program (PEBC)

Introducing Roberto de la Rica Quesada

Pío González-Fernández - Professor of Applied Physics

Beyond ELISA: ultrasensitive detection of disease biomarkers via enzyme-guided nanoparticle growth

Roberto de la Rica Quesada - Research Fellow in Stevens' Group, Imperial College London

Questions. Beyond ELISA: ultrasensitive detection of disease biomarkers via enzyme-guided nanoparticle growth

Roberto de la Rica Quesada - Research Fellow in Stevens' Group, Imperial College London

Introducing Miriam López Álvarez

Pío González-Fernández - Professor of Applied Physics

Designing scaffolds for bone tissue engineering: from bioinspired ceramics to nanomaterials

Miriam López Álvarez - New Materials Group, Applied Physics Dpt., School of Industrial Engineering

Questions. Designing of scaffolds for bone tissue engineering: from bioinspired ceramics to nanomaterials

Miriam López Álvarez - New Materials Group, Applied Physics Dpt., School of Industrial Engineering

Introducing Fernando Rodríguez Artalejo

Francisco Calvo Iglesias - Head of Cardiology Section

Impact of health behaviors on quality of life and mortality among older adults

Fernando Rodríguez Artalejo - Professor of Preventive Medicine and Public Health

Questions. Impact of health behaviors on quality of life and mortality among older adults

Fernando Rodríguez Artalejo - Professor of Preventive Medicine and Public Health

Research lines in BIOCAPS Ageing and Cardiovascular Diseases Area: from bedside to bench

Carlos Rodríguez Pascual - Department of Geriatric Medicine, Hospital Meixoeiro

Questions. Research lines in BIOCAPS Ageing and Cardiovascular Diseases Area: from bedside to bench

Carlos Rodríguez Pascual - Department of Geriatric Medicine, Hospital Meixoeiro

Introducing Pablo Blanco Martínez de Moretín

Federico Mallo Ferrer - Department of Functional Biology and Health Sciences

AMPK in the hypothalamic control of energy metabolism

Pablo Blanco Martínez de Morentín - Department of Physiology, School of Medicine

Questions. AMPK in the hypothalamic control of energy metabolism

Pablo Blanco Martínez de Morentín - Department of Physiology, School of Medicine

Introducing Antonio Fernández

José Manuel Olivares Díez - Department of Psychiatry

Introducing Jaume Reventós

Gloria García López - Director

Creation of innovative technology-based companies in the public health system

Jaume Reventós - Research Unit in Biomedicine and Translational and Pediatric Oncology

Questions. Creation of innovative technology-based companies in the public health system

Jaume Reventós - Research Unit in Biomedicine and Translational and Pediatric Oncology

BIOCAPS (Biomedical Capacities Support Program)

África González-Fernandez - Coordinator

Presentación de Andrew Mckenzie

África González-Fernández - Coordinadora

Células linfoides innatas do grupo 2 na inmunidade e na enfermidade

Andrew Mckenzie - Laboratorio de Bioloxía Molecular MRC

Presentación de Luis Anibarro García

África González-Fernández - Coordinadora

Infección de tuberculosis latente

Luis Anibarro García - Unidade de Tuberculose

Turno de preguntas. Infección de tuberculosis latente

Luis Anibarro García - Unidade de Tuberculose

Benvida institucional

José Manuel Olivares Díez - Presidente

Presentación de Andre Fischer

Roberto Carlos Agis-Balboa - Investigador Senior